Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux-Reference-Cited by-同舟云学术

Type 2 diabetes-induced overactivation of P300 contributes to skeletal muscle atrophy by inhibiting autophagic flux

Published:2020-10 Issue: Volume:258 Page:118243
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

Fan Zhen,Wu Jing,Chen Qiu-nan,Lyu An-kang,Chen Jin-liang,Sun Yue,Lyu Qiong,Zhao Yu-xing,Guo Ai,Liao Zhi-yin,Yang Yun-fei,Zhu Shi-yu,Jiang Xu-shun,Chen Bo,Xiao Qian

Funder

Natural Science Foundation of Chongqing

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference50 articles.

1. Global estimates of diabetes prevalence for 2013 and projections for 2035;Guariguata;Diabetes Res. Clin. Pract.,2014

2. Premature loss of muscle mass and function in type 2 diabetes;Guerrero;Diabetes Res. Clin. Pract.,2016

3. Decreased muscle strength and quality in older adults with type 2 diabetes: the health, aging, and body composition study;Park;Diabetes,2006

4. Autophagy inhibition induces atrophy and myopathy in adult skeletal muscles;Eva;Autophagy,2010

5. Mechanisms of muscle growth and atrophy in mammals and Drosophila;Piccirillo;Dev. Dyn.,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of transcriptomics and proteomics for analyzing potential biomarker and molecular mechanism underlying skeletal muscle atrophy;Journal of Proteomics;2024-10

2. Epigenetics of Skeletal Muscle Atrophy;International Journal of Molecular Sciences;2024-07-31

3. Epigenetic control of skeletal muscle atrophy;Cellular & Molecular Biology Letters;2024-07-08

4. Autophagy and lysosomal dysfunction in diabetes and its complications;Trends in Endocrinology & Metabolism;2024-07

5. Characteristics of anticancer activity of CBP/p300 inhibitors – Features of their classes, intracellular targets and future perspectives of their application in cancer treatment;Pharmacology & Therapeutics;2024-05